Bacteriophage endolysin Ply113 as a potent antibacterial agent against polymicrobial biofilms formed by enterococci and Staphylococcus aureus
Frontiers in Microbiology · 12.12.2023 · 14
DOI: 10.3389/fmicb.2023.1304932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.12.2023. Verfasst von Jing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbi…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Antibiotic resistance in Enterococcus faecium , Enterococcus faecalis , and Staphylococcus aureus remains a major public health concern worldwide. Furthermore, these microbes frequently co-exist in biofilm-associated infections, largely nullifying antibiotic-based therapy. Therefore, it is imperative to develop an efficient therapeutic strategy for combating infections caused by polymicrobial biofilms. In this study, we investigated the antibacterial and antibiofilm activity of the bacteriophage endolysin Ply113 in vitro . Ply113 exhibited high and rapid lytic activity against E. faecium , E. faecalis , and S. aureus , including vancomycin-resistant Enterococcus and methicillin-resistant S. aureus isolates. Transmission electron microscopy revealed that Ply113 treatment led to the detachment of bacterial cell walls and considerable cell lysis. Ply113 maintained stable lytic activity over a temperature range of 4–45°C, over a pH range of 5.0–8.0, and in the presence of 0–400 mM NaCl. Ply113 treatment effectively eliminated the mono-species biofilms formed by E. faecium , E. faecalis , and S. aureus in a dose-dependent manner. Ply113 was also able to eliminate the dual-species biofilms of E. faecium – S. aureus and E. faecalis – S. aureus . Additionally, Ply113 exerted potent antibacterial efficacy in vivo , distinctly decreasing the bacterial loads in a murine peritoneal septicemia model. Our findings suggest that the bacteriophage endolysin Ply113 is a promising antimicrobial agent for the treatment of polymicrobial infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Liang, S., Lu, X., Xu, Q., Zhu, Y., Yu, S., Zhang, W., Liu, S., & Xie, F. (2023). Bacteriophage endolysin Ply113 as a potent antibacterial agent against polymicrobial biofilms formed by enterococci and Staphylococcus aureus. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1304932
Vancouver
Wang J, Liang S, Lu X, Xu Q, Zhu Y, Yu S, et al. Bacteriophage endolysin Ply113 as a potent antibacterial agent against polymicrobial biofilms formed by enterococci and Staphylococcus aureus. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1304932
BibTeX
@article{Wang2023,
author = {Wang, Jing and Liang, Siyu and Lu, Xiaofeng and Xu, Qiu and Zhu, Yao and Yu, Shenye and Zhang, Wanjiang and Liu, Siguo and Xie, Fang},
title = {Bacteriophage endolysin Ply113 as a potent antibacterial agent against polymicrobial biofilms formed by enterococci and Staphylococcus aureus},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1304932}
}
EUVIMED